Makora, a startup founded by assistant professor Mohamed Abdelfattah, has received a $1.75 million award from the National Science Foundation-supported STRIDE Ventures AI Efficiency Challenge.
An experimental opioid painkiller designed to be reversibly switched on and off with different light frequencies may eliminate the dangerous side effects of current opioids, according to a study co-led by Weill Cornell medicine researchers.
Researchers at Weill Cornell Medicine, working with zebrafish, have discovered a new cell type that may help regulate blood vessel growth in the heart during development and in response to injury.
Surgery to remove lymph nodes in the neck may interfere with cerebrospinal fluid (CSF) drainage from the brain, contributing to cognitive impairment, according to new multicenter research led by Weill Cornell Medicine scientists.
The discovery research center could uncover molecular markers that enable new diagnostics and lead to potential therapies for people living with neurological complications related to HIV.
Financial strategies can advance sustainability goals, but only if environmental trade-offs can be measured and incorporated into decisions, a panel of experts said at a Climate Week NYC 2026 event co-hosted by the SC Johnson College and Cornell Atkinson.
Weill Cornell Medicine investigators have determined the mechanism by which a molecule within cells can help tune the light sensitivity of the eyes, a finding that should enable the development of drugs that target this site to treat related eye diseases.
As an undergraduate researcher, Maya Mangala-Munuma '25 found that trees were three times more likely to be damaged in impoverished, racially diverse neighborhoods.
Chronic stress may contribute to the pain and urinary symptoms experienced by people with interstitial cystitis/bladder pain syndrome by triggering changes in the bladder and nervous system, according to Weill Cornell investigators.
